🔎 Trials Near Me

Hjem › Kreft (alle typer) › Ohio

Kliniske studier for Kreft (alle typer) i Ohio

85 studier for Kreft (alle typer) søker deltakere på steder i Ohio.

Byer i Ohio

Offisiell studietekst (engelsk)

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

  • GSK Investigational Site, Columbus
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06796907

Met Non Small Cell Cancer Registry (MOMENT)

  • The Ohio State University Wexner Medical Center, Columbus
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05376891

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • University of Cincinnati Medical Center. /ID# 278925, Cincinnati
  • University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 1. okt. 2026 · NCT07024784

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Case Western, Cleveland
  • Taylor Cancer Research Center, Maumee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07192471

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  • Oncology Hematology Care Clinical Trials, LLC, Fairfield
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07566156

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • Ohio State University, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05874921

Registry Study for Radiation Therapy Outcomes

  • University of Cincinnati Medical Center, Cincinnati
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT01255748

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, Canton
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06881992

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • The Ohio State University, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07195591

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04981119

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06979596

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Rekrutterer
Alder 15 til 24 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07223463

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 8, Columbus
RekruttererFase 3
Alder 18 til 71 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07504458

Pan Tumor Rollover Study

  • Oncology Hematology Care, Cincinnati
  • The Ohio University, Columbus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03899155

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Oncology Hematology Care - Fairfield /ID# 280641, Fairfield
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07365241

Visugromab in Cachexia International Trial

  • Cleveland Clinic Avon Hospital, Avon
  • Cleveland Clinic (Main Campus), Cleveland
  • Cleveland Clinic Fairview Hospital, Fairview
  • og 1 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07112196

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • University of Cincinnati Medical Center, Cincinnati
  • Kettering Health, Kettering
  • West Chester Hospital, West Chester
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Oncology Hematology Care, Inc., Cincinnati
  • University Hospitals of Cleveland, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • og 1 flere
RekruttererFase 2/3
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

  • Ohio State University, Columbus
RekruttererObservasjonsstudie
2 Months · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00900198

Statins to Prevent Cancer Associated Blood Clots

  • Cleveland Clinic Foundation, Cleveland
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07303816

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  • GSK Investigational Site, Canton
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07213609

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

  • University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05796375

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Miami Valley Hospital South, Centerville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT05386108

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Miami Valley Hospital South, Centerville
  • USO - Oncology Hematology Care, Cincinnati
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • University of Cincinnati, Cincinnati
  • Cleveland Clinic, Cleveland
  • Ohio State University, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06163534

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Gabrail Cancer & Research Center, Canton
  • Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

  • Children's Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Rainbow Babies and Childrens Hospital, Cleveland
  • og 5 flere
RekruttererObservasjonsstudie
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

  • Cleveland Clinic, Cleveland
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06678659

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05335928

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626

International Rare Brain Tumor Registry

  • Akron Children's Hospital, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererObservasjonsstudie
Opp til 45 år · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05697874

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • Nationwide Children's Hosp, Columbus
RekruttererFase 2
Alder 1 til 39 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • OhioHealth O'Bleness Hospital, Athens
  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • Geauga Hospital, Chardon
  • og 26 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 2
Alder 19 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06129747

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07541365

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.